Gulinuer Wumaier

No.12 Urumqi Middle Road
Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

The Case | Rash, eosinophilia, adrenal mass, and acute kidney injury in a febrile patient.

The Case | Rash, eosinophilia, adrenal mass, and acute kidney injury in a febrile patient.

Journal: Kidney international
Published: June 25, 2025

The interplay between M2-like macrophages and Th17.1 cells promotes the progression of early-stage sarcoidosis.

The interplay between M2-like macrophages and Th17.1 cells promotes the progression of early-stage sarcoidosis.

Journal: Cell communication and signaling : CCS
Published: May 26, 2025

Characterizations of lung cancer microbiome and exploration of potential microbial risk factors for lung cancer.

Characterizations of lung cancer microbiome and exploration of potential microbial risk factors for lung cancer.

Journal: Scientific reports
Published: January 17, 2025

Design, synthesis, and biological evaluation of diphenyl ether substituted quinazolin-4-amine derivatives as potent EGFRL858R/T790M/C797S inhibitors.

Design, synthesis, and biological evaluation of diphenyl ether substituted quinazolin-4-amine derivatives as potent EGFRL858R/T790M/C797S inhibitors.

Journal: European journal of medicinal chemistry
Published: July 17, 2024

NDRG1 promotes endothelial dysfunction and hypoxia-induced pulmonary hypertension by targeting TAF15.

NDRG1 promotes endothelial dysfunction and hypoxia-induced pulmonary hypertension by targeting TAF15.

Journal: Precision clinical medicine
Published: July 19, 2023

CDK10 suppresses metastasis of lung adenocarcinoma through inhibition of the ETS2/c-Raf/p-MEK/p-ERK signaling loop.

CDK10 suppresses metastasis of lung adenocarcinoma through inhibition of the ETS2/c-Raf/p-MEK/p-ERK signaling loop.

Journal: Molecular carcinogenesis
Published: June 21, 2023

Discovery and optimization of 4-anilinoquinazoline derivatives spanning ATP binding site and allosteric site as effective EGFR-C797S inhibitors.

Discovery and optimization of 4-anilinoquinazoline derivatives spanning ATP binding site and allosteric site as effective EGFR-C797S inhibitors.

Journal: European journal of medicinal chemistry
Published: June 18, 2022

EphrinA3 is a key regulator of malignant behaviors and a potential prognostic factor in lung adenocarcinoma.

EphrinA3 is a key regulator of malignant behaviors and a potential prognostic factor in lung adenocarcinoma.

Journal: Cancer medicine
Published: March 26, 2022

Mxi1-0 Promotes Hypoxic Pulmonary Hypertension Via ERK/c-Myc-dependent Proliferation of Arterial Smooth Muscle Cells.

Mxi1-0 Promotes Hypoxic Pulmonary Hypertension Via ERK/c-Myc-dependent Proliferation of Arterial Smooth Muscle Cells.

Journal: Frontiers in genetics
Published: November 06, 2021

PTPL1 suppresses lung cancer cell migration via inhibiting TGF-β1-induced activation of p38 MAPK and Smad 2/3 pathways and EMT.

PTPL1 suppresses lung cancer cell migration via inhibiting TGF-β1-induced activation of p38 MAPK and Smad 2/3 pathways and EMT.

Journal: Acta pharmacologica Sinica
Published: August 04, 2020

Design, synthesis and biological evaluation of potent EGFR kinase inhibitors against 19D/T790M/C797S mutation.

Design, synthesis and biological evaluation of potent EGFR kinase inhibitors against 19D/T790M/C797S mutation.

Journal: Bioorganic & medicinal chemistry letters
Published: April 16, 2020

Protein tyrosine phosphatase L1 represses endothelial-mesenchymal transition by inhibiting IL-1β/NF-κB/Snail signaling.

Protein tyrosine phosphatase L1 represses endothelial-mesenchymal transition by inhibiting IL-1β/NF-κB/Snail signaling.

Journal: Acta pharmacologica Sinica
Published: August 18, 2019
Showing 1-12 of 13

Last Updated: 09/26/2026